Alaska Clinical Trials
Browse actively recruiting clinical trials with research sites in Alaska. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Alaska
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsNCT06581432PHASE2Boehringer IngelheimSolid TumoursAnchorage, AK
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNCT07128199PHASE3Taiho Oncology, Inc.Lung CancerAnchorage, AK
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)NCT06824467PHASE3Merck Sharp & Dohme LLCOvarian CancerAnchorage, AK
- Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyNCT04269902PHASE3National Cancer Institute (NCI)Chronic Lymphocytic LeukemiaAnchorage, AK
- APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationNCT04858334PHASE2National Cancer Institute (NCI)Pancreatic Acinar Cell CarcinomaAnchorage, AK
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)NCT07144280PHASE3PfizerNon-small Cell CarcinomaAnchorage, AK
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaNCT06307665PHASE3AstraZenecaAsthmaAnchorage, AK
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)NCT06952504PHASE3Merck Sharp & Dohme LLCEndometrial CancerAnchorage, AK
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the LungNCT05058651PHASE2, PHASE3National Cancer Institute (NCI)Advanced Extrapulmonary Neuroendocrine CarcinomaAnchorage, AK
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951PHASE3AstraZenecaBreast Cancer, Early Breast CancerAnchorage, AK
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)NCT07216703PHASE3Merck Sharp & Dohme LLCCervical CancerAnchorage, AK
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerNCT06058377PHASE3National Cancer Institute (NCI)Anatomic Stage II Breast Cancer AJCC v8Anchorage, AK
Popular conditions in Alaska
Frequently asked questions
- How do I find clinical trials in Alaska?
- Corterve aggregates actively recruiting clinical trials with sites in Alaska from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Alaska free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Alaska?
- Alaska research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.